Clinical Trial Update: Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a dual antihypertensive therapy plus sibutramine versus placebo in obese hypertensives has completed and reports on blood pressure and w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Dual antihypertensive combination therapy
• Sibutramine (sibutramine)

Snippet

Sponsor: Abbott | Conditions: Obesity, Hypertension | Phase 3 | Status: COMPLETED